与衰老相关的肠功能障碍损害了5-heptadecylresorcinol的吸收:对载体介导吸收,屏障完整性和炎症调节的机制性见解
Kuiliang Zhang1, Hao Zhang1, Yujie Sun1
1State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
Food research international (Ottawa, Ont.)
|May 13, 2025
概括
全谷物成分5-heptadecylresorcinol (AR-C17) 的吸收因肠道变化而随着年龄的增长而下降. 这影响了它的抗衰老功效,特别是在老年人中.
科学领域:
- 营养科学 营养科学
- 胃肠病学 胃肠病学
- 衰老研究研究 衰老研究
背景情况:
- 在全谷物中发现的5-heptadecylresorcinol (AR-C17) 有抗衰老特性.
- 肠道吸收AR-C17和与年龄相关的差异尚不清楚.
研究的目的:
- 为了研究AR-C17在不同部分的肠道吸收.
- 为了比较年轻和老年小鼠之间的AR-C17吸收.
- 阐明年龄相关的吸收差异背后的机制.
主要方法:
- 使用室内系统来评估肠道部分的AR-C17吸收.
- 测量表面透率系数,膜阻力和短路电流.
- 载体的组织病理学分析和基因表达分析 (Oct1,Octn2).
主要成果:
- 体和皮质是AR-C17的主要吸收部位 (年轻小鼠的吸收率为60%).
- 老年小鼠的AR-C17吸收显著降低 (20-45%).
- 衰老导致了肠道结构损伤,降低了Oct1/Octn2表达的调节,改变了输送器功能,炎症和紧张的结节.
结论:
- 衰老显著影响AR-C17的肠道吸收.
- 老化小鼠的肠道功能障碍是AR-C17吸收减少的原因.
- 研究结果为提高全谷物生物活性化合物在老年人中的生物可用性提供了见解.
相关概念视频
Factors Influencing Drug Absorption: Disease States and Pharmacology
348
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
348
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
156
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
156
Drugs for Treatment of Ulcerative Colitis in IBD
106
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
106
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
146
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
146
Chronic Bowel Disorders: Introduction
325
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
325
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
178
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
178


